Published in Blood Weekly, July 7th, 2005
According to scientists in Germany, "Activation of coagulation and fibrinolysis is common among patients undergoing cardiopulmonary bypass (CPB) surgery. Little is known, however, about the impact of myocardial ischemia and reperfusion on coagulation activation and fibrinolysis in this clinical setting."
G. Kalweit and colleagues of the Voelklingen Heart Center wrote, "We determined the levels of coagulation activation and fibrinolysis markers (CAFM) in 19 patients with severe coronary heart...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.